Published in Reumatol Clin on December 20, 2008
Barriers to lose weight from the perspective of children with overweight/obesity and their parents: a sociocultural approach. J Obes (2014) 0.76
Developing Community-Based Rehabilitation Programs for Musculoskeletal Diseases in Low-Income Areas of Mexico: The Community-Based Rehabilitation for Low-Income Communities Living With Rheumatic Diseases (CONCORD) Protocol. JMIR Res Protoc (2014) 0.76
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol (1999) 2.62
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 2.27
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2009) 1.42
Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis (2001) 1.25
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Features of spondyloarthritis around the world. Rheum Dis Clin North Am (1998) 1.13
Validation of a Spanish version of the Childhood Health Assessment Questionnaire. J Rheumatol (1997) 1.11
Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis (2005) 1.09
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis (2002) 1.03
Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (2006) 1.02
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis (2006) 1.02
Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.99
Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol (1998) 0.98
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
Intradermal tophi in gout: a case-control study. J Rheumatol (1999) 0.97
Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis Rheum (1999) 0.97
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis (2002) 0.93
Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) (2001) 0.90
Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus (2009) 0.89
The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis (1997) 0.88
TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin Exp Rheumatol (2002) 0.88
Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol (1995) 0.88
Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum (2009) 0.87
Severe tophaceous gout. Characterization of low socioeconomic level patients from México. Clin Exp Rheumatol (2006) 0.87
Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) (2000) 0.87
HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol (2005) 0.86
Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol (2014) 0.85
Update on functional assessment tools. J Rheumatol Suppl (2000) 0.84
HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol (1997) 0.83
Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2006) 0.83
Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients. Clin Exp Rheumatol (2009) 0.83
Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol (1995) 0.82
Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol (1997) 0.82
[Juvenile ankylosing spondylitis: clinical characteristics in 41 patients]. Bol Med Hosp Infant Mex (1985) 0.81
Antibodies to peptidoglycan in juvenile onset ankylosing spondylitis and pauciarticular onset juvenile arthritis associated with chronic iridocyclitis. J Rheumatol (1986) 0.81
Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol (2000) 0.81
Association of HLA DRB1 alleles with juvenile idiopathic arthritis in Mexicans. Clin Exp Rheumatol (2010) 0.80
The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol (2010) 0.80
IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients. Scand J Rheumatol (2002) 0.80
Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann Rheum Dis (2010) 0.80
Illness trajectories in Mexican children with juvenile idiopathic arthritis and their parents. Rheumatology (Oxford) (2006) 0.79
Anterior spinal flexion in healthy Mexican children. J Rheumatol (1985) 0.79
Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol (2009) 0.78
Antibody pattern and other criteria for diagnosis and classification in PSS. J Rheumatol (1988) 0.78
Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.78
Assessment of quality of life in children with rheumatic disease. J Rheumatol (1999) 0.78
The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 0.78
A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 0.77
Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J Rheumatol (1998) 0.77
Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis (2004) 0.77
Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb Pathog (2000) 0.77
Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid. J Clin Pathol (2007) 0.77
Novel concepts of severity mechanisms in ankylosing spondylitis. J Rheumatol (2001) 0.75
Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scand J Rheumatol (2010) 0.75
Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase. Rev Latinoam Microbiol (1997) 0.75
[Clinical study of dermato/polymyositis with onset in childhood]. Bol Med Hosp Infant Mex (1987) 0.75
Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases. Reumatol Clin (2008) 0.75
Systemic features and early prognostic factors in Hispanic and non-Hispanic children from the United States of America and Mexico with systemic juvenile idiopathic arthritis. Clin Exp Rheumatol (2008) 0.75
Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms. J Rheumatol (1988) 0.75
[Recognition and diagnosis of juvenile ankylosing spondylitis: clinical analysis and comparative study of juvenile rheumatoid arthritis]. Bol Med Hosp Infant Mex (1988) 0.75
[Axial involvement in juvenile ankylosing spondylitis]. Bol Med Hosp Infant Mex (1988) 0.75
Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout. J Clin Rheumatol (2000) 0.75
Uveitis of juvenile ankylosing spondylitis. J Rheumatol (1988) 0.75
[Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study]. Rev Invest Clin (1984) 0.75